Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Retatrutide, the triple-action GLP-1/GIP/glucagon receptor agonist, outperforms tirzepatide by 23% in the latest human clinical trialthe most comprehensive weight loss comparison to date
The pill uses the same active ingredientsemaglutidethat has proven so effective in the injectable form
Ren W, Wang W, Guo Y
Unlike earlier treatments like Wegovy or Mounjaro, which focus on one or two hormone receptors, Retatrutide targets three
There are three primary areas where these injections should be given: the abdomen, upper arm, and thigh
US$ 29.47
US$ 29.22
US$ 25.46
